The North American Menopause Society (NAMS)

Manson on Women's Health

Should BP Guidelines Be Sex-Specific? New data show that the risk for CVD death among women increases at lower systolic blood pressures than it does among men.
Medscape Ob/Gyn, December 18, 2023

Benign Ovarian Cysts: Will They Resolve Spontaneously? Benign Ovarian Cysts: Will They Resolve Spontaneously?
Medscape Ob/Gyn, December 21, 2023

From Menopause

The official journal of NAMS publishes original research from around the world.

Join NAMS and receive a subscription to Menopause.

The Complexity of Genitourinary Syndrome of Menopause
September 2023
Cervical Cancer Screening in Menopause: When Is It Safe to Exit?
September 2023
Testosterone for HSDD in Postmenopausal Women
July 2023
Diagnosis, Causes, and Treatment of Postmenopausal Dyspareunia
June 2023
Severity of Menopausal Symptoms, CVD, and All-cause Mortality
December 2022

NAMS Position Statements & OTHER REPORTS

The official Society positions published in Menopause offer practical recommendations regarding key menopause issues.

NAMS: The 2017 Hormone Therapy Position Statement
February 2018
Nonhormonal Management of Vasomotor Symptoms of Menopause
January 2016
Use of Systemic Hormone Therapy After Age 65
July 2015
NAMS: The 2012 Hormone Therapy Position Statement
March 2012
NAMS Position Statement: Management of Osteoporosis
June 2011

About The North American Menopause Society

The North American Menopause Society (NAMS) is the leading nonprofit organization dedicated to promoting the health and quality of life of all women during midlife and beyond through an understanding of menopause and healthy aging. Its multidisciplinary membership of 2,000+ leaders in the field—including clinical and basic science experts from medicine, nursing, sociology, psychology, nutrition, anthropology, epidemiology, pharmacy, and education—allows NAMS to be uniquely qualified to provide information that is both accurate and unbiased.

Resources

Menopause News & Perspectives on Medscape »